Hostname: page-component-7b7567c8c-tnzcf Total loading time: 0 Render date: 2026-11-12T18:16:31.573Z Has data issue: false hasContentIssue false

Cognitive dysfunctions in multiple sclerosis

Published online by Cambridge University Press:  31 July 2026

V. R. Enătescu*
Affiliation:
Neuroscience, University of Medicine and Pharmacy “Victor Babes” Timisoara, Timisoara, Romania

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.
Abstract

Cognitive dysfunctions cause pervasive and significant disabilities in people with multiple sclerosis. This will increase the global burden of the disease. Different domains of cognition are not equally affected by multiple sclerosis. Among the vulnerable domains of cognition impaired by multiple sclerosis, it should be noted that information processing speed (IPS), verbal memory, visual memory, prospective memory, executive functions, visuospatial processing, language functions, and social cognition are affected. So far, studies have revealed that cognitive dysfunctions in people with multiple sclerosis negatively impact the quality of life, disease management, risk of falls, driving, financial management skills, employment, and attending social and leisure activities. Moreover, their caregiver partners’ health-related quality of life is also diminished. Three batteries are widely used to objectively assess cognition in persons with multiple sclerosis: the Brief Repeatable Battery of Neuropsychological Tests (BRB-N), the Minimal Assessment of Cognitive Function in MS (MACFIMS), and the Brief International Cognitive Assessment for MS (BICAMS). There are a lot of other psychiatric comorbidities or complications of multiple sclerosis that should be identified and treated, such as anxiety, depression, apathy, organic personality disorder, psychoactive substance abuse, and even suicide. All these conditions may worsen the cognitive impairments in people with multiple sclerosis. Some of the psychiatric comorbidities could be a direct consequence of disease-modifying therapy in multiple sclerosis. Whatever the case, the management of this subclinical population of people with multiple sclerosis and cognitive dysfunctions needs specific management, consisting of specific social, psychological, and pharmacological interventions.

Keywords

cognitive dysfunctions, multiple sclerosis, disabilities

References

1. Anonymous, Stern EB. A mind “surrounded by a moat”: a first-person account of cognitive impairment in multiple sclerosis. Cogn Behav Neurol. 2011 Dec;24(4):217-26.

2. Costa SL, Genova HM, DeLuca J, Chiaravalloti ND. Information processing speed in multiple sclerosis: Past, present, and future. Mult Scler. 2017 May;23(6):772-789.

3. De Meo E, Portaccio E, Giorgio A, et al. Identifying the Distinct Cognitive Phenotypes in Multiple Sclerosis. JAMA Neurol. 2021 Apr 1;78(4):414-425.

Disclosure of Interest

None Declared

Information

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2026. Published by Cambridge University Press on behalf of European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.